Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, lambda
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1, kappa
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1
EY6A
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
IgG
SCT630
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
IgG1-kappa
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
IgG4-kappa
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
IgG1-kappa
General
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Chimeric
IgG1-kappa
Human
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
IgG1-nd